Day: August 27, 2024
-
FDA Approves Updated COVID-19 Vaccines for Omicron KP.2 Strain Amid Concerns Over Relevance and Safety
The FDA has approved updated mRNA COVID-19 vaccines from Pfizer and Moderna targeting the Omicron variant KP.2, despite the lack of released clinical trial data. These vaccines are recommended for everyone aged 6 months and older. Critics, including several doctors and scientists, have expressed concern over the safety and necessity of these vaccines given their…